1 / 17

Alexander V. Sergeev, MD, PhD, MPH Irina B. Bazina, MD, PhD Smolensk State Medical Academy

Low Adherence of Hypertension Patients to Treatment – What Is To Be Done? Clinical Problem for Public Health. Alexander V. Sergeev, MD, PhD, MPH Irina B. Bazina, MD, PhD Smolensk State Medical Academy Smolensk, Russia. Hypertension: is it really dangerous?.

gterri
Download Presentation

Alexander V. Sergeev, MD, PhD, MPH Irina B. Bazina, MD, PhD Smolensk State Medical Academy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Low Adherence of Hypertension Patients to Treatment – What Is To Be Done? Clinical Problem for Public Health Alexander V. Sergeev, MD, PhD, MPH Irina B. Bazina, MD, PhD Smolensk State Medical Academy Smolensk, Russia

  2. Hypertension: is it really dangerous? • People don’t die of hypertension itself, but … they die of its complications • Target organ damage (heart, brain, kidneys) • CHD and stroke are causes of disability and death

  3. Hypertension & Public Health • High prevalence  burden from public health perspective • BP over 140/90 in over 1/3 of adult population • Particular concern: high prevalence among workforce

  4. Hypertension: actual problem for Russia • Rise in mortality from the major complications of hypertension – CHD and stroke – during the last 20 years • High prevalence among workforce • Early disability; decreased life expectancy

  5. The problem of hypertension patients’ low compliance to therapy • Low percentage of those who take medications regularly and have their BP controlled effectively • Decrease in compliance among males as compared to 1980s • Patients’ attitude to their health • Low priority of health on one’s values scale • Being inadequately informed of disease The result is sad: Irregular treatment cannot stabilize BP at safe level

  6. Objective • To analyze the factors associated with low adherence of hypertension patients to treatment • To work out recommendations on development of population level approaches to solving the problem of low adherence from public health perspective

  7. Methods • Study design: cross-sectionalstudy • Study population: essential hypertension (stages I-III) patients of young age (22-45 yrs old) • Catchment area: employees of organizations located in Smolensk Oblast • N=224 • Questionnaire: questions pertaining to knowledge of hypertension and attitude to various aspects of the disease including the necessity of treatment

  8. Statistical Analysis • Binary outcome variable • Probability of getting negative answer to the question: “Do you think that hypertension patients should be on permanent treatment?” • Multiple logistic regression – simultaneous control for a number of factors influencing binary outcome variable • SAS software, PROC GENMOD

  9. “Do you think that hypertension patients should be on permanent treatment?” • 101 (45.09%) patients gave negative answer

  10. Factors associated with hypertension patients’ noncompliance/compliance to treatment

  11. Low adherence risk group • Short length of disease • No clinical sequelae of hypertension (asymptomatic patients)

  12. What can be expected of risk group? • Behavioral pattern and peculiarities of self-perception of the disease • Anosognosic attitude to the disease “I feel OK even when my blood pressure is 180/110. And 170/100 is my usual BP. So, there is no need for treatment, and I am not going to see the doctor!”

  13. Health Belief Model • Patient: subjective perception of health status and disease severity • Physician: objective assessment Who is right?

  14. What can be done to improve the situation? • Low effectiveness of individual level influences • Need for population level influences • Information campaigns analogous to social advertising

  15. The cost of the medicine and adherence: myths and realities • Cost is not a major determinant • Free medications cannot guarantee adequate adherence

  16. Physicians and public health professionals against low compliance – who should be the leader? • Interdisciplinary task • Public health professionals’ competence in population level influences

  17. Thank you!

More Related